EFDID: 437332EFD: View Filing

Issuer: GENEOS Therapeutics, Inc. (0001769177) - D

Accession: 0001769177-22-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001769177
  • Entity Name:
    GENEOS Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    660 WEST GERMANTOWN PIKE
    SUITE LL100
    PLYMOUTH MEETING, PA 19462
  • Persons:
    Related Persons 7
    Niranjan Sardesai
    Executive Officer, Director
    Eadie James
    Director
    Joseph Kim
    Director
    Casey Cunningham
    Director
    Samuel Broder
    Director
    Sangwoo Lee
    Director
    Ted Fjallman
    Director
EDGAR: Offering Information
  • Accession Date:
    03/28/2022
  • First Sale Date:
    03/21/2022
  • Offering Amount:
    $25,000,000
  • Amount Sold:
    $17,249,984
  • Amount Remaining:
    $7,750,016
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:PA, TX
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
GENEOS Therapeutics, Inc./s/ Niranjan Y. SardesaiNiranjan Y. SardesaiChief Executive Officer2022-03-28